Skip to main content
. Author manuscript; available in PMC: 2024 Jan 23.
Published in final edited form as: Drug Metab Rev. 2020 Jul 9;52(3):333–365. doi: 10.1080/03602532.2020.1772281

Figure 11.

Figure 11.

Proposed metabolic pathways and novel metabolites of pazopanib. (A) Formation of aldehyde metabolites M14 and M15. (B) Structures of N-oxide metabolite, M3, and (C) cysteine adduct, M18. Pazopanib metabolite structures were elucidated by high-resolution mass spectrometry and tandem MS fragmentation patterns (Wang et al., 2019).